Microvascular hypertensive disease, Long COVID, and end-organ pathology

被引：0
|
作者：
Nevio Cimolai
机构：
[1] The University of British Columbia and,Faculty of Medicine
[2] Children’s and Women’s Health Centre of British Columbia,undefined
来源：
Hypertension Research | 2023年 / 46卷
关键词：
COVID-19; Long COVID; Hypertension; Microvascular; Pathology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
[graphic not available: see fulltext]
引用
收藏
页码：2247 / 2248
页数：1
相关论文
共 50 条
  • [41] Relation between indices of end-organ damage and mean platelet volume in hypertensive patients
    Bulur, Serkan
    Onder, Halil Ibrahim
    Aslantas, Yusuf
    Ekinozu, Ismail
    Kilic, Ali Cagri
    Yalcin, Subhan
    Bulur, Sule
    Ozhan, Hakan
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (05) : 367 - 369
  • [42] Rheological parameters of end-organ damages
    Leschke, M
    Klimek, W
    Jung, F
    INTERNIST, 2003, 44 (07): : 853 - +
  • [43] Spectrum of Eosinophilic End-Organ Manifestations
    Akuthota, Praveen
    Weller, Peter F.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (03) : 403 - +
  • [44] Molecular mechanisms of end-organ resistance
    Jameson, JL
    GROWTH HORMONE & IGF RESEARCH, 2004, 14 : S45 - S50
  • [45] End-organ protection in cardiac surgery
    De Somer, F.
    MINERVA ANESTESIOLOGICA, 2013, 79 (03) : 285 - 293
  • [46] END-ORGAN DEAFNESS - DIAGNOSIS AND SIGNIFICANCE
    SIMONTON, KM
    ARCHIVES OF OTOLARYNGOLOGY, 1956, 63 (03): : 262 - 269
  • [47] The heart: an end-organ of GH action
    Colao, A
    Vitale, G
    Pivonello, R
    Ciccarelli, A
    Di Somma, C
    Lombardi, G
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 : S93 - S101
  • [48] HORMONAL ACTIVITY AND END-ORGAN RESPONSE
    ZONDEK, H
    LANCET, 1968, 2 (7566): : 510 - &
  • [49] Rituximab/antineoplasticsCytomegalovirus infection and end-organ disease: 12 case reports
    Reactions Weekly, 2015, 1545 (1) : 212 - 212
  • [50] Cytomegalovirus antigenemia and end-organ disease in Japanese patients treated with bendamustine
    Chiba, Akira
    Nakamura, Fumihiko
    Nakazaki, Kumi
    Kurokawa, Mineo
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 749 - 751
12345